Evidence map›Paper›PMID 38550378›Full record

ReviewFrontiers in cell and developmental biology2024

Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects.

Qianzi Liu, Linxi Lv, Xueding Cai, Jiandong Zhu, Jifa Li, Lehe Yang, Xiaona Xie, Chengguang Zhao, Haiyang Zhao

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. RNA modifications and cancer ferroptosis.Cancer cell international · 2026
    Review
  3. Enhancer regulation in cancer: from epigenetics to mArchives of pharmacal research · 2025
    Review
  4. Article
  5. Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Qianzi LiuInstitute of Life Sciences, Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, Zhejiang, China.
Linxi LvThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xueding CaiThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jiandong ZhuAffiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jifa LiAffiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lehe YangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiaona XieThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chengguang ZhaoAffiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Haiyang ZhaoInstitute of Life Sciences, Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, Zhejiang, China.
Wenzhou Medical University · CNWenzhou University · CNFirst Affiliated Hospital of Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N

Indexed as

cancercorrelationferroptosisN6-methyladenosineregulation

Identifiers

PMID38550378
PMCPMC10976581
OpenAlexW4392757836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.